18 employees
Wilson Therapeutics focuses on developing novel therapies addressing unmet medical needs in rare diseases.
2012
$40M
from 3 investors over 3 rounds
Wilson Therapeutics raised $40M on April 16, 2014
Investors: MVM Partners, HealthCap and Abingworth